Cala Health Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
124
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$77M
- Investors
-
23
Cala Health General Information
Description
Developer of neuromodulation devices created to optimize the standard of care for chronic diseases. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its vertically integrated commercial model is reshaping the delivery of prescription therapies, enabling patients to reduce tremors and ensure relief.
Contact Information
Website
www.calahealth.com
Formerly Known As
Resido Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
- 1800 Gateway boulevard
- Suite 300
- San Mateo, CA 94404
- United States
+1 (415) 000-0000
Cala Health Timeline
Cala Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series D) | 16-Nov-2021 | $77M | 00000 | 00000 | Completed | Generating Revenue |
| 6. Later Stage VC (Series C) | 21-May-2019 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
| 5. Accelerator/Incubator | 000.00 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 16-Feb-2016 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
| 3. Early Stage VC (Series A) | 02-Jul-2014 | 00.00 | 00.00 | 00.00 | Completed | Generating Revenue |
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Grant | 01-Jan-2013 | $35K | Completed | Startup |
Cala Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series B | 28,946,332 | $0.000100 | $0.08 | $1.04 | $1.04 | 1x | $1.04 | 19.02% |
| Series A | 8,208,955 | $0.000100 | $0.03 | $0.4 | $0.4 | 1x | $0.4 | 5.39% |
Cala Health Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of neuromodulation devices created to optimize the standard of care for chronic diseases. The company's wearab
Therapeutic Devices
San Mateo, CA
124
As of 2022
00000
0000
0000-00-00
00000000000
00000
00000
fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia de
00000000000 0000000
Lausanne, Switzerland
00
As of 0000
000.00
0000000 0000
000.00
000000
dunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco la
00000000000 0000000
Munich, Germany
00
As of 0000
0000000000 0
Add Comparison
Cala Health Competitors (48)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aleva Neurotherapeutics | Private Equity-Backed | Lausanne, Switzerland | 00 | 000.00 | 0000000 0000 | 000.00 |
| 00000000 | Venture Capital-Backed | Munich, Germany | 00 | 0000000000 0 | ||
| 000000 | Venture Capital-Backed | Trumbull, CT | 00 | 000.00 | 0000000000 | 000.00 |
| 000000 00000000000 | Venture Capital-Backed | Eindhoven, Netherlands | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000000000000 | Venture Capital-Backed | Austin, TX | 00 | 00000 | 00000000000 | 00000 |
Cala Health Patents
Cala Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220233860-A1 | Wearable peripheral nerve stimulation for the treatment of diseases utilizing rhythmic biological processes | Pending | 08-Mar-2019 | 00000000000 | |
| AU-2020234681-A1 | Wearable peripheral nerve stimulation for the treatment of diseases utilizing rhythmic biological processes | Pending | 08-Mar-2019 | 00000000000 | |
| EP-3934736-A1 | Wearable peripheral nerve stimulation for the treatment of diseases utilizing rhythmic biological processes | Pending | 08-Mar-2019 | 00000000000 | |
| CA-3130147-A1 | Wearable peripheral nerve stimulation for the treatment of diseases utilizing rhythmic biological processes | Pending | 08-Mar-2019 | 00000000000 | |
| AU-2019364532-A1 | Nerve stimulation for treating migraine and other headache conditions | Pending | 24-Oct-2018 | A61N1/36021 |
Cala Health Executive Team (9)
Cala Health Board Members (13)
| Name | Representing | Role | Since |
|---|---|---|---|
| Asha Nayak Ph.D | Johnson & Johnson Innovation - JJDC | Board Member | 000 0000 |
| John Kuelper JD | Ascension Ventures | Board Member | 000 0000 |
| Juan-Pablo Mas | Action Potential Venture Capital | Board Observer | 000 0000 |
| Kate Rosenbluth Ph.D | Cala Health | Co-Founder, Chief Scientific Officer and Board Member | 000 0000 |
| Michael Carusi | Lightstone Ventures | Board Member | 000 0000 |
Cala Health Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Cala Health Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Ascension Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Dolby Family Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Innovatus Capital Partners | Asset Manager | Minority | 000 0000 | 000000 0 | |
| Johnson & Johnson Innovation - JLABS | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| MBC BioLabs | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |